Previous close | 17.35 |
Open | 17.32 |
Bid | 17.40 x 100 |
Ask | 17.93 x 100 |
Day's range | 17.32 - 17.78 |
52-week range | 8.90 - 38.85 |
Volume | |
Avg. volume | 67,481 |
Market cap | 434.383M |
Beta (5Y monthly) | 2.00 |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
SAN DIEGO, April 25, 2024 (GLOBE NEWSWIRE) -- Cibus, Inc. (Nasdaq: CBUS), a leading agricultural biotechnology company that uses proprietary gene editing technologies to develop plant traits (or specific genetic characteristics) in seeds, today announced that the company will report first quarter 2024 financial results on Thursday, May 9, 2024. Cibus’ management team will host a conference call and audio webcast at 4:30 p.m. ET on that day to discuss the financial results and other company updat
Completed successful transfers of gene edited elite germplasm back to customers for commercialization for each of its three developed productivity traits: Pod Shatter Reduction (PSR) in Canola and Herbicide Tolerance (HT1 and HT3) in Rice Signed collaboration agreements for trait development with multiple major seed companies, including Bayer, Loveland Products (subsidiary of Nutrien Ltd), Nuseed, and Interoc Reported achievement of successful greenhouse results for two different modes of action
Agricultural biotechnology company joins the ranks of Nvidia, YouTube, Taco Bell, and moreSAN DIEGO, March 19, 2024 (GLOBE NEWSWIRE) -- Cibus, Inc. (Nasdaq: CBUS), a leading agricultural biotechnology company that uses proprietary gene editing technologies to develop plant traits (or specific genetic characteristics) in seeds, today announced that it has been named to Fast Company’s prestigious list of the World’s Most Innovative Companies of 2024, ranking as the 2nd most innovative company in t